Palliative Geriatric Care — Evidence-Based Clinical Guide — Cost, Top Hospitals & Success Rates | MyMedicPlus

Palliative geriatric care sits at the intersection of two complementary medical specialties — geriatric medicine and palliative medicine — and applies the principles of both to the care of older people living with serious, life-limiting illness and frailty. This integrated approach recognises that older adults facing the end of life have distinct needs that differ from those of younger adults or patients with a single terminal condition: they commonly present with multimorbidity (five or more chronic conditions), polypharmacy (ten or more regular medications), cognitive impairment or dementia, physical frailty, nutritional vulnerability, and complex psychosocial circumstances involving family caregivers, residential care facilities, and limited social networks.

The geriatric-palliative interface is codified in the United Kingdom by NICE guideline NG142 — "Care of dying adults in the last days of life" — which emphasises individualised assessment, honest communication, comfort-focused intervention, and dignity as central to high-quality end-of-life care. Internationally, the World Health Organization endorses an integrated palliative-geriatric approach as essential for equitable, person-centred care of ageing populations.

A central assessment framework is the Comprehensive Geriatric Assessment (CGA) — a multidimensional, interdisciplinary diagnostic and treatment process that evaluates medical, functional, cognitive, psychological, social, and environmental status. In palliative settings, CGA is adapted to focus on symptom burden, goals of care, advance care planning, support needs, and functional trajectory rather than on rehabilitation potential alone. CGA-guided care in palliative settings has been shown to reduce inappropriate acute hospital admissions, improve patient-reported quality of life, and increase the proportion of older patients who die in their preferred setting.

Frailty assessment using the Clinical Frailty Scale (CFS) — a validated nine-point ordinal scale ranging from CFS 1 (very fit) to CFS 9 (terminally ill) — provides a rapid, clinically useful measure of biological age and vulnerability that informs both prognosis and the appropriateness of interventions. Patients scoring CFS 6 (moderately frail), CFS 7 (severely frail), CFS 8 (very severely frail), or CFS 9 (terminally ill) are typically those most likely to benefit from palliative integration.

Palliative geriatric care is appropriate for a wide range of age-related and chronic conditions encountered in older adults, particularly when curative or disease-modifying treatment is no longer beneficial, tolerated, or desired by the patient.

• Advanced Dementia (all types): Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia all have progressive, terminal trajectories. In advanced stages, patients lose the ability to recognise family members, communicate verbally, walk, swallow safely, and maintain continence. Recognising dementia as a terminal illness — rather than a cognitive problem managed indefinitely — is fundamental to appropriate palliative planning.
• Frailty Syndrome: Older adults with CFS scores of 6–9, characterised by unintentional weight loss, exhaustion, weakness, slowness, and low physical activity, have high one-year mortality and benefit from palliative symptom support alongside optimised functional support. Frailty is not a normal part of ageing but a distinct clinical syndrome with measurable outcomes.
• Multimorbidity in Advanced Age: Patients aged 80 and above commonly live with combinations of heart failure, COPD, chronic kidney disease, diabetes, osteoporosis, and cancer. The cumulative symptom burden, medication complexity, and functional impact of multimorbidity justify a palliative-geriatric integrated approach even when no single condition is dominant.
• Advanced Cancer in Older Adults: Older patients with cancer face additional challenges — comorbid conditions limiting chemotherapy tolerance, age-related pharmacokinetic changes, greater symptom vulnerability, and less social support. Oncological and palliative geriatric integration improves treatment decision-making and quality of life.
• End-Stage Neurological Conditions: Progressive neurological diseases including Parkinson's disease, motor neurone disease (ALS/MND), progressive supranuclear palsy, and multiple system atrophy all predominantly affect older adults and require palliative symptom management including dysphagia assessment, dysarthria support, and respiratory management.
• Hip Fracture and Post-Surgical Frailty: Hip fracture in very old, frail patients carries six-month mortality of 20–35%. Palliative goals-of-care discussions are essential alongside surgical decision-making in this population.

Palliative geriatric care is appropriate for older patients identified as having a life-limiting condition with high symptom burden, declining functional trajectory, or where the goals of care are shifting from cure or stabilisation toward comfort, dignity, and quality of remaining life.

Key eligibility indicators include:

• Clinical Frailty Scale (CFS) score of 6–9 with ongoing functional decline
• Advanced dementia with loss of swallowing, recurrent aspiration pneumonia, or contractures
• Age 80 and above with multimorbidity, polypharmacy, and two or more acute hospitalisations in the past year
• Residential care or nursing home residence with deteriorating nutritional status and recurrent infections
• Patient or family expressing preference for comfort-focused goals over life-prolonging treatment
• Clinician answer of "No" to the surprise question: "Would I be surprised if this patient died in the next 12 months?"

Cognitive impairment must be carefully assessed — the Montreal Cognitive Assessment (MoCA) or MMSE should be used to establish whether the patient has capacity to participate in advance care planning. Advance care planning should begin while the patient retains capacity, even in early-to-moderate dementia, rather than being deferred until capacity is lost. Documented lasting power of attorney (LPA) or equivalent healthcare proxy designations should be identified and consulted early.

NICE NG142 specifically recommends that clinical teams should recognise the possibility that a person may be in the last hours or days of life, communicate this clearly and compassionately to both patient and family, and document an individual care plan. The guideline emphasises that clinicians should not withhold this information due to prognostic uncertainty — it is appropriate to acknowledge uncertainty while still enabling meaningful planning.

Residential care facility staff should be supported with structured training in recognising dying, anticipatory prescribing, and palliative care documentation to reduce unnecessary emergency hospital transfers from care homes in the final days of life.

Palliative geriatric care encompasses a structured set of clinical interventions adapted to the vulnerabilities and priorities of older adults at end of life.

Comprehensive Geriatric Assessment in Palliative Settings: A palliative-adapted CGA evaluates: symptom burden (using IPOS or ESAS), cognitive and functional status, nutritional needs, psychosocial support, carer assessment, advance care planning status, current medication appropriateness, and preferred place of care. The MDT — geriatrician, palliative medicine physician, specialist nurse, occupational therapist, physiotherapist, dietitian, social worker, and chaplain — reviews the CGA findings and agrees on a person-centred care plan.

Polypharmacy Deprescribing: Older patients at end of life commonly take ten or more regular medications, many of which confer no benefit and increase side effect burden. Systematic deprescribing using validated tools such as the STOPPFrail criteria or the Beers Criteria identifies medications to discontinue: preventive medications (statins, bisphosphonates, antihypertensives to tight targets, anticoagulants in terminal falls risk), medications with significant anticholinergic burden (oxybutynin, tricyclics), and medications causing polypharmacy-related falls, confusion, or constipation. Deprescribing reduces pill burden, adverse drug reactions, and hospital admissions without reducing quality of life.

Dysphagia and Feeding Decisions in Advanced Dementia: Dysphagia — difficulty or inability to swallow safely — is universal in advanced dementia. A landmark Cochrane systematic review (Sampson et al., 2009, updated 2022) found no survival benefit, no reduction in aspiration pneumonia, no improvement in nutritional status, and no improvement in quality of life from percutaneous endoscopic gastrostomy (PEG) tube feeding in patients with advanced dementia. NICE NG142 recommends that tube feeding should not be offered routinely to patients with advanced dementia with dysphagia. Instead, comfort or assisted oral feeding — offering small amounts of preferred foods and fluids for pleasure and comfort — is the recommended evidence-based approach. This respects patient dignity, avoids the complications of tube insertion (infection, tube displacement, restraint distress), and aligns with palliative principles.

Dignity-Conserving Care: Chochinov's dignity therapy model identifies seven empirical domains of dignity in dying patients: illness-related concerns (symptoms, uncertainty), dignity-conserving repertoire (continuity of self, role preservation, generativity, hope, autonomy), and social dignity inventory (privacy, social support, care tenor). Structured dignity therapy — a brief psychotherapeutic intervention creating a document of meaningful life memories and messages for family — reduces psychological distress and increases sense of purpose in older patients approaching death.

Symptom Management: Pain assessment in cognitively impaired older patients uses validated observational tools (Abbey Pain Scale, PAINAD). Delirium management prioritises non-pharmacological approaches (orientation, familiar faces, hydration, regular toileting) before pharmacological sedation.

The integration of palliative and geriatric principles produces measurable benefits for older patients, their families, and healthcare systems when implemented early and systematically.

• Reduced Inappropriate Hospital Admissions: Older patients with palliative care plans and care home staff trained in recognising dying are significantly less likely to be transferred to hospital in the final days of life. Studies show that up to 40% of emergency hospital admissions from care homes in the final week of life are potentially avoidable with adequate community palliative support.
• Improved Symptom Control: CGA-guided symptom management in older patients with advanced disease achieves greater improvement in pain, breathlessness, constipation, and delirium scores than standard ward-based care. Older patients are often under-treated for pain due to clinician concerns about opioid side effects — palliative geriatric expertise supports appropriate, dose-adjusted opioid use.
• Preferred Place of Death: Older patients with documented advance care plans and community palliative support are more likely to die in their preferred location — care home, own home, or hospice — rather than in acute hospital, which is the least preferred setting for most older adults.
• Reduction in Unwanted Interventions: Documented advance care plans prevent unwanted cardiopulmonary resuscitation attempts, invasive ventilation, and admission to intensive care in older patients for whom these interventions are unlikely to be beneficial and are not desired by the patient.
• Deprescribing Benefits: Systematic polypharmacy review and deprescribing in frail older patients reduces falls, confusion, constipation, urinary retention, and hospital admissions attributable to adverse drug reactions — a significant source of morbidity in this population.
• Family and Carer Support: Family caregivers of older patients with dementia or frailty carry very high caregiver burden. Palliative geriatric teams offer structured support, education about the dying process, and clear communication that reduces anticipatory grief, family conflict, and post-bereavement psychological morbidity.
• Dignity and Meaning: Dignity therapy and psychosocial support provided by palliative geriatric teams allow older patients to maintain a sense of self, purpose, and connection in their final period, improving subjective wellbeing even as physical function declines.

Palliative geriatric care navigates several important clinical risks, system-level challenges, and complex ethical dimensions that require careful professional judgement, patient and family engagement, and institutional support.

• Pain Under-Treatment in Dementia: Cognitive impairment reduces the ability of patients to self-report pain, leading to systematic under-recognition and under-treatment. Observational pain assessment tools (Abbey Pain Scale, PAINAD) must be used consistently. Clinician hesitancy to prescribe opioids in older patients due to concerns about sedation, respiratory depression, or falls risk can result in avoidable suffering.
• Delirium Risk: Older patients at end of life are highly vulnerable to delirium — an acute confusional state with agitated or hypoactive presentations that increases distress for patients and families. Opioids, benzodiazepines, and anticholinergic medications can precipitate or worsen delirium. Palliative sedation with carefully titrated midazolam may be required for refractory agitated delirium in the terminal phase.
• Capacity Fluctuation: Dementia and delirium cause fluctuating decision-making capacity, which complicates consent processes. Clinicians must assess capacity at each decision point rather than assuming global incapacity. Best interests decision-making under mental capacity legislation requires documented evidence of consultation with family, carers, lasting power of attorney holders, and the palliative team.
• Family Disagreement About Feeding: Despite strong Cochrane evidence that tube feeding in advanced dementia does not improve survival or quality of life, family members and sometimes staff may resist the decision not to insert a feeding tube, viewing it as "starvation." Compassionate, evidence-based communication — ideally by a senior clinician or palliative specialist — is required to support families through this decision.
• Inequity in Palliative Access: Older patients, particularly those in care homes, from ethnic minority backgrounds, or with dementia, consistently receive less access to specialist palliative care compared to younger cancer patients. Addressing this inequity requires both clinician awareness and systemic investment in community-based geriatric palliative services.
• Medication Risks in Frailty: Frail older patients are highly sensitive to medications. Standard adult doses of opioids, sedatives, and antiemetics can cause disproportionate sedation, respiratory depression, or paradoxical agitation. Conservative dosing with close monitoring is essential.

Follow-up in palliative geriatric care requires particularly careful coordination across multiple providers — hospital specialists, geriatricians, primary care physicians, community nurses, care home staff, and family carers — given the complex, multi-setting trajectories of older patients at end of life.

Regular CGA Review: Palliative CGA should be repeated at each significant clinical change: following an acute hospitalisation, after a functional decline, following a change in cognitive status, or after a residential care transition. The frequency of formal review ranges from monthly outpatient assessment for stable patients to weekly multidisciplinary review for patients in the final weeks of life.

Advance Care Planning Documentation: ACP documents should be updated regularly as the patient's condition changes and, where cognitive decline is progressive, while the patient retains capacity. Documents must be accessible across all care settings — paper copies should accompany the patient, and electronic copies should be accessible to out-of-hours services, ambulance crews, care home staff, and family. DNACPR orders and ReSPECT (or equivalent) forms require regular review for currency and relevance.

Medication Review Frequency: Polypharmacy deprescribing is not a one-time intervention but an ongoing process requiring reassessment at each clinical contact. As function declines and oral intake reduces in the final days of life, routes of administration must be changed from oral to subcutaneous (via syringe driver), and all non-essential medications discontinued. NICE NG142 provides explicit guidance on medicines management in the final days of life, including continuation of analgesics and discontinuation of preventive medications.

Residential Care Transitions: Transfer from home to residential care, or from residential care to nursing home, is a high-risk transition for older patients with palliative needs. Planned transitions — with pre-admission CGA, documented care plans, confirmed anticipatory medication supply, and named key workers — reduce crisis hospital admissions and unmet symptom needs in the first weeks following transition.

Bereavement Care for Families: Families of older patients with dementia and frailty often experience a prolonged period of anticipatory grief before death. Structured bereavement support — including family meetings after death, information about normal grief responses, and referral to bereavement counselling services — should be offered routinely. Care home staff who form close bonds with residents over years also benefit from access to bereavement support and reflective practice.

The economic dimensions of palliative geriatric care are shaped by the long-duration, multi-setting nature of frailty and dementia trajectories, and the substantial costs of acute hospital care that appropriate palliative planning can avoid.

• Specialist Geriatric Palliative Consultation: Integrated geriatric-palliative assessment adds modest direct costs but generates measurable savings through reduction in acute hospital stays, unnecessary investigations, and avoidable emergency admissions. A geriatric palliative MDT review typically costs USD 200–500 per comprehensive assessment but averts acute care costs many times greater.
• Care Home Costs: Residential care home fees in high-income countries range from USD 800–3,500 per week depending on care level, country, and funding model. In many healthcare systems these costs are partially or wholly self-funded by patients and families. Appropriate palliative care in the care home reduces hospital transfer costs and enables residents to die in their familiar environment — the preference of most older adults.
• Community Palliative and Nursing Support: Community palliative nursing, Admiral nurses (dementia specialist nurses in the UK), district nursing, and GP home visits collectively enable community-based end-of-life care. The cost of community-based palliative support (typically USD 50–200 per nursing visit) is substantially lower than equivalent hospital-based care.
• Deprescribing Savings: Systematic polypharmacy review generates direct medication cost savings and — through reducing adverse drug reactions and fall-related injury admissions — substantial indirect savings. Analysis of deprescribing programmes in frail older patients estimates average medication cost savings of USD 300–800 per patient per year.
• Avoiding Intensive Care: For very frail, older patients, admission to intensive care in the final weeks of life represents the most expensive and frequently least beneficial use of healthcare resources. An ICU bed costs USD 2,000–10,000 per day in most high-income countries. Advance care planning that clearly documents goals and treatment preferences prevents these admissions in many cases.
• Anticipatory Prescribing: Pre-supply of a "just in case" medication pack — typically containing subcutaneous morphine, midazolam, haloperidol, and hyoscine — to care homes and patient homes prevents delays in symptom management and avoids unnecessary emergency calls. The cost of an anticipatory medication pack is typically under USD 50 but averts ambulance call and potential emergency admission costs.

Palliative geriatric care complements rather than replaces other legitimate approaches to the care of older adults. Understanding the full range of options enables older patients, their families, and clinical teams to make truly informed decisions.

• Continued Active Medical Management: Some older patients, despite frailty or advanced dementia, have clear preferences for continued active treatment of acute conditions (infections, heart failure decompensation, fractures). Active medical care can be provided in a manner consistent with geriatric palliative values — with careful attention to comfort, dignity, and avoidance of non-beneficial interventions. Active and palliative goals need not be mutually exclusive.
• Geriatric Rehabilitation: For patients with reversible functional decline following acute illness or hospitalisation, comprehensive geriatric rehabilitation — including physiotherapy, occupational therapy, and speech and language therapy — can restore function and enable return to preferred living environment. Palliative and rehabilitative goals should be held concurrently and re-evaluated as the patient's trajectory becomes clearer.
• Specialist Dementia Care: Behavioural and psychological symptoms of dementia (BPSD) — agitation, psychosis, wandering, sleep disturbance — can often be managed without pharmacological sedation through specialist dementia care environments, structured activity, music therapy, and person-centred care approaches. These should be tried before antipsychotic or sedative prescribing, which carries significant adverse effect risks in this population.
• Percutaneous Endoscopic Gastrostomy (PEG) — When Appropriate: Although PEG tube feeding is not recommended for advanced dementia, it may be appropriate for selected older patients with neurological dysphagia who are not cognitively impaired (e.g., early Parkinson's disease, motor neurone disease) where the patient has capacity, wishes the intervention, and is expected to benefit in terms of quality of life and symptom management.
• Assisted Oral Feeding: As the evidence-based and dignity-preserving alternative to tube feeding in advanced dementia, assisted oral feeding — offering preferred foods and fluids in small quantities for comfort and pleasure — maintains connection and relationship between patient and caregiver. Speech and language therapists guide safe swallowing strategies and advise on texture modification.
• Complementary and Spiritual Care: Music therapy, reminiscence therapy, spiritual care, pet therapy, and sensory stimulation all have patient-reported benefit in older patients with dementia and frailty, supporting wellbeing and sense of self when verbal communication is limited.